RUBICON is a “Network of Excellence” funded by the Framework Programme 6 of the European Commission over a five years period (January 2006 – December 2010). It is coordinated by Professor Maria Masucci, Karolinska Institutet, Stockholm, Sweden.
The mysterious paradox of a carcinogenic poison which also acts as a cancer treatment has been unravelled by Ron Hay’s group in a recent paper publ... » more
The Italian Life Sciences Federation (FISV - Federazione Italiana Scienze della Vita) is having its annual congress in Riva del Garda. The congress... » more
The idea that the immune system can recognize and respond to tumors was formed in the late 19th century when William Coley, a surgeon at the Memori... » more
The purpose of the group’s research is to investigate how ubiquitin and ubiquitin like proteins regulate different intracellular processes in the f... » more
Research in our group centers around posttranslational modification with small ubiquitin-related proteins of the SUMO family. Like ubiquitin, these... » more
The secretory pathway of eukaryotic cells harbors an elaborate protein quality control system, which prevents the accumulation of misfolded or unas... » more
The group focuses on the analysis of two signaling pathways : NF-kappaB and Notch. More specifically, ex vivo approaches based on biochemical and g... » more
We are studying signal transduction pathways incorporating phosphorylation and ubiquitination, in particular the NF-kB and Wnt signaling pathways.... » more
The major focus of the lab is the functional identification of novel cancer-relevant genes. The completion of the sequencing of the human genome in... » more
